Article Text

Download PDFPDF
Generative adversarial networks to predict treatment response for neovascular age-related macular degeneration: interesting, but is it useful?
  1. T Y Alvin Liu1,
  2. Sina Farsiu2,
  3. Daniel S Ting3
  1. 1 Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA
  2. 2 Ophthalmology, Duke University, Durham, North Carolina, USA
  3. 3 Vitreo-Retinal Department, Singapore National Eye Center, Singapore, Singapore
  1. Correspondence to Daniel S Ting, Singapore National Eye Center, Duke-NUS Medical School, 11 Third Hospital Avenue, Singapore, Singapore; daniel.ting.s.w{at}singhealth.com.sg

Statistics from Altmetric.com

Generative adversarial networks (GANs)1 are deep learning (DL) methods, which are in turn a type of machine learning. In recent years, DL methods have been applied extensively in medicine and in ophthalmology, mainly for image classification, for example, for detecting glaucoma,2–5 age-related macular degeneration (AMD),2 6–9 diabetic retinopathy2 10–13 and retinopathy of prematurity.14 As the name suggests, GANs are used not to classify images but to generate images, and have two main components. The first ‘generative’ network uses the training data to generate synthetic images, which are then presented to the second ‘discriminative’ network that is responsible for discriminating between the synthetic and real images. The two networks are ‘adversarial’ in that the ‘generative’ network aims to generate synthetic images that can ‘fool’ the ‘discriminative’ network. These two networks are then trained reiteratively against each other to ultimately maximise the ‘authenticity’ of the synthetic images. GANs have been applied in ophthalmology in several contexts. For example, they have been used to generate colour fundus photographs with different stages of AMD,15 improve the segmentation of anterior segment optical coherence tomography (OCT),16 create autofluorescence images …

View Full Text

Footnotes

  • Contributors TYAL, SF and DST have drafted, critically appraised and finally approved the editorial.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests Dr Ting is the section editor of British Journal of Ophthalmology and a patent holder of a deep learning system for retinal diseases.

  • Provenance and peer review Commissioned; internally peer reviewed.

  • Data availability statement Not applicable.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.